Jeevan Scientific Technology Faces Financial Struggles Amid Significant Stock Volatility

Jeevan Scientific Technology, a microcap player in the healthcare services sector, has experienced significant volatility today, hitting a new 52-week low of Rs. 35.3. This decline marks a notable underperformance, with the stock down 7.57% intraday and trailing the sector by 4.61%. The stock has struggled to maintain momentum, reversing direction after two consecutive days of gains.
In terms of moving averages, Jeevan Scientific Technology is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a persistent downward trend. Over the past year, the stock has seen a substantial decline of 36.55%, contrasting sharply with the Sensex, which has only dipped by 1.25% during the same period.

The company's financial health appears concerning, with a reported net sales drop of 31.68% and negative operating profits. The inventory turnover ratio stands at a low 28.92 times, and the operating profit to net sales ratio is at -20.23%. These metrics suggest ongoing challenges in maintaining profitability and operational efficiency. As the market continues to react, Jeevan Scientific Technology remains under scrutiny for its performance and financial stability.